![Dale Pfost](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dale Pfost
Président chez Biopticon Corp.
Fortune : 114 $ au 30/06/2024
Postes actifs de Dale Pfost
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biopticon Corp.
![]() Biopticon Corp. Medical SpecialtiesHealth Technology Biopticon Corp. operates as a developer, manufacturer, and marketer of measurement and data management systems for pre clinical animal studies. It offers Tumorimager 2, Tumorimager, and Tumormanager. The company was founded by Ibrahim Cem Girit in 2004 and is headquartered in Princeton, NJ. | Président | 17/10/2011 | - |
Directeur/Membre du Conseil | 17/10/2011 | 17/10/2011 | |
AxoSim, Inc.
![]() AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Président | 28/02/2024 | - |
Directeur/Membre du Conseil | - | 28/02/2024 | |
Ancilia Biosciences, Inc.
![]() Ancilia Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ancilia Biosciences, Inc. is an American company that is developing virus-resistant live bacterial biotherapeutics to alter the gut microbiome and treat disease. Ancilia is based in the United States, and its founders and advisers include key scientific leaders across CRISPR and the virome. Ancilia's proprietary platform is being developed as an essential enabling technology that characterizes viral phages and leverages the natural function of CRISPR to produce a new class of live biotherapeutics with engineered immunity to key viral pathogens. The company has demonstrated proof of principle and filed key patents for the technology. The company was founded to overcome a potential obstacle to the success of LBPs, which is their failure to address the role of predatory viral phages in causing disease and limiting the ability of LBPs to engraft in the gut. The company was founded by Alexandra Sakatos, who has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/05/2021 | - |
Historique de carrière de Dale Pfost
Anciens postes connus de Dale Pfost
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Directeur/Membre du Conseil | 01/09/2021 | 19/12/2021 |
Directeur Général | 01/09/2021 | 01/06/2023 | |
Président | 19/12/2021 | 01/06/2023 | |
Lodo Therapeutics Corp.
![]() Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Directeur Général | 20/12/2019 | 01/01/2021 |
Président | - | 01/01/2021 | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 25/11/2010 | 01/01/2019 |
MicroBiome Therapeutics LLC
![]() MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Directeur/Membre du Conseil | 01/01/2009 | 01/01/2019 |
Directeur Général | 01/01/2016 | 01/01/2019 | |
Fondateur | 01/01/2009 | 01/01/2019 | |
Vestagen Protective Technologies, Inc.
![]() Vestagen Protective Technologies, Inc. Industrial MachineryProducer Manufacturing Vestagen Protective Technologies, Inc. manufactures and markets textile products and technologies. Its technologies include vestex protective fabric, fluid barrier technology, semeltec antimicrobial protection, WarpDry technology and professional appearance. The company was founded in 2009 by Benjamin Uncas Favret and is headquartered in Orlando, FL. | Directeur Général | 21/07/2015 | 08/02/2016 |
Président | 01/01/2013 | 01/01/2017 | |
Receptor BioLogix, Inc.
![]() Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Directeur Général | 01/01/2008 | 01/01/2009 |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ | - | - |
Formation de Dale Pfost
Brown University | Doctorate Degree |
University of California | Undergraduate Degree |
University of California, Santa Barbara | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 19 |
Royaume-Uni | 4 |
Israël | 2 |
Opérationnelle
Director/Board Member | 9 |
Chief Executive Officer | 8 |
Chairman | 8 |
Sectorielle
Health Technology | 10 |
Commercial Services | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
CALETHOS, INC. | Finance |
AURA BIOSCIENCES, INC. | Health Technology |
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Entreprise privées | 16 |
---|---|
Acuity Pharmaceuticals, Inc.
![]() Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | Commercial Services |
eXegenics, Inc. | Health Technology |
Oxford GlycoSciences Plc
![]() Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Receptor BioLogix, Inc.
![]() Receptor BioLogix, Inc. BiotechnologyHealth Technology Receptor BioLogix, Inc. provides receptor based biological therapeutics. It develops an intron fusion protein platform for the discovery of novel alternative forms splice variants of human proteins with therapeutic potential. The company was founded by H. Michael Shepard, John P. Adelman and Gail M. Clinton on May 27, 2003 and is headquartered in Mountain View, CA. | Health Technology |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Biopticon Corp.
![]() Biopticon Corp. Medical SpecialtiesHealth Technology Biopticon Corp. operates as a developer, manufacturer, and marketer of measurement and data management systems for pre clinical animal studies. It offers Tumorimager 2, Tumorimager, and Tumormanager. The company was founded by Ibrahim Cem Girit in 2004 and is headquartered in Princeton, NJ. | Health Technology |
Nicoventures Trading Ltd.
![]() Nicoventures Trading Ltd. Industrial ConglomeratesProducer Manufacturing Nicoventures Trading Ltd. researches, develops, manufactures and delivers tobacco harm reduction products and services. The firm provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. The company develops ortfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. The company was founded by Christopher John Lord and David Thomas Newns in September 2008 and is headquartered in Manchester, the United Kingdom. | Producer Manufacturing |
MicroBiome Therapeutics LLC
![]() MicroBiome Therapeutics LLC Pharmaceuticals: MajorHealth Technology MicroBiome Therapeutics LLC develops drug therapies for metabolic diseases. Its microbiome modulators are designed to augment the growth of certain desirable bacterial strains and discourage the growth of others. The company was founded by John B. Elstrott and Dale R. Pfost in 2009 and is headquartered in New Orleans, LA. | Health Technology |
Vestagen Protective Technologies, Inc.
![]() Vestagen Protective Technologies, Inc. Industrial MachineryProducer Manufacturing Vestagen Protective Technologies, Inc. manufactures and markets textile products and technologies. Its technologies include vestex protective fabric, fluid barrier technology, semeltec antimicrobial protection, WarpDry technology and professional appearance. The company was founded in 2009 by Benjamin Uncas Favret and is headquartered in Orlando, FL. | Producer Manufacturing |
Orchid Cellmark, Inc.
![]() Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
Infinitek Solutions | |
Lodo Therapeutics Corp.
![]() Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Health Technology |
AxoSim, Inc.
![]() AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Technology Services |
Smithkline Beckman Corp
![]() Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Smithkline Beckman Corp is a company that manufactures pharmaceutical products. The company is based in Philadelphia, PA. Smithkline Beckman was acquired by Smithkline Beecham Plc on July 27, 1989 for $16,082.37 million. | Health Technology |
Bioelectronica Corp.
![]() Bioelectronica Corp. Packaged SoftwareTechnology Services Bioelectronica Corp. is a research-stage biotechnology company that specializes in building intelligent, digital tools for drug discovery, cell screening, and cell sorting. The company is based in Reno, NV. The company's platform technology combines computer vision, biochemical reagents, and consumer electronics to accelerate discovery. Bioelectronica was founded by Roger Chen and Jonathan Hull. | Technology Services |
Ancilia Biosciences, Inc.
![]() Ancilia Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ancilia Biosciences, Inc. is an American company that is developing virus-resistant live bacterial biotherapeutics to alter the gut microbiome and treat disease. Ancilia is based in the United States, and its founders and advisers include key scientific leaders across CRISPR and the virome. Ancilia's proprietary platform is being developed as an essential enabling technology that characterizes viral phages and leverages the natural function of CRISPR to produce a new class of live biotherapeutics with engineered immunity to key viral pathogens. The company has demonstrated proof of principle and filed key patents for the technology. The company was founded to overcome a potential obstacle to the success of LBPs, which is their failure to address the role of predatory viral phages in causing disease and limiting the ability of LBPs to engraft in the gut. The company was founded by Alexandra Sakatos, who has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Dale Pfost
- Expérience